throbber
THIRD EDITION
`
`I-eoon
`
`' Effects on the Eyes and Visual System from
`Chemicals, Drugs, Metals and Minerals,
`Plants, Toxins and Venoms; also,
`Systemic Side Effects from Eye Medications
`
`
`By
`
`W. MORTON GRANT, M.D.
`David Glendmning Cogan Professor qf Ophthalmology, Emeritus
`. Harvard Univem'gy Medical School
`' Home Laboratory of Ophthalmology
`Massachusetts Eye and Ear Irgfirmaiy
`
`
`
`TOXICOLOGY
`OF THE EYE
`
`
`
`
`
`
`
`
`
`
`
`
`[ms~15;knew"(4Ala'e‘-M‘q‘1w~fiz\w14¢M‘-...,........-Ai..,A1<Jnv
`
`
`
`
`CHARLES C THOMAS 0 PUBLISHER
`~
`
`
`
`..
`
`Springfield 0
`
`Illinois 0 U.S.A.
`
`
`
`Argentum Pharm. LLC v. Alcon Research, Ltd.
`Case IPR2017-01053
`
`ALC ON 2 I 25
`
`

`

`Published and Distributed Thmughout the Win-Id by
`CHARLES C. THOMAS . PUBLISHER
`2600 South First Street
`
`Springfield, Illinois 62717
`
`This book is protected by copyright. No part of it
`may be reproduced in any manner without written
`permission from the publisher.
`
`0 1986 by CHARLES C THOMAS - PUBLISHER
`ISBN 0-398-05184-4
`
`Library of Congress Catalog Card Number: 85-17366
`
`With THOMAS BOOKS mmfut attention 1': given to at! details of manufacturing and
`design. It is the Publisher’s data: to present Books that are satzkfactmjt as to (Heir physical
`qualities and artistic fwssibilx‘tfus and appropriate [or their particular use. THOMAS
`BOOKS will be true to those laws of quatity that assure a gnod name and good mitt.
`
`Printed in the United States ofAmm'ca
`SC—R-E}
`
`Library of Congrss Cataloging-in-Publicafian Data
`
`Gram, W. Morton (Walter Morton), 1915-
`Toxicology of the eye.
`
`Bibliography: 13.
`.
`Includes index.
`2. Toxicology.
`1. Eye—Diseases and defects.
`I. Title.
`[DNLMz 1. Eye Injuries-chemically induced.
`2. Vision Disorders—chemically induced‘ WW [0067631]
`RE901.T67G73
`1936
`617.7'1
`'
`85—17366
`ISBN 0898051844
`
`

`

`
`
`986
`
`’beicology of the Eye
`
`due to accumulation of xylitol, electrolytes and water when D—xylose is added to the
`medium. Addition of an aldose reductase inhibitor prevents these effects of xylose,
`demonstrating the primary role of this enzyme in the cataractogenic process, similar
`to its role in experimental galactose cataracts.
`
`a. Obazawa H, Merola L0, Kimoshita JH: The effects of xylose on the isolated lens.
`INVEST OPHTHALMOL 13:204-209. 1974.
`b. Patterson JW, Bunting KW: Sugar cataracts, polyol levels and lens swelling. DOCUM
`OPHTHALMOL 20:64—72, 1966.
`
`c. Schrader RE: Morphology and pathogenesis of experimental xylose cataract. GRAEFES
`ARCH OPHTHALMOL 163:422—443, 1961. (German)
`d. Van Heyningen R: Xylose cataract; A comparison between the weanling and the older
`rat. EXP E YE RES 8:379-385, 1969.
`
`Xylyl bromides and chlorides (including o-, mm, and p-isomers) are strongly
`lacrimatory.“l
`
`(See also BromOxylene.)
`
`1 aqueous
`:
`Ytterbium chloride tested on rabbit eyes by applying 0.1 ml of l
`solution at pH 3.05 to 3.78, caused “conjunctival irritation“ and ulceration which
`healed in ninety-six hours.”
`
`Yttrium chloride applied to rabbit eyes as a 0.1 M solution (pH 5.4) for ten minutes
`caused no injury. but similar exposure of eyes from which the corneal epithelium
`had been removed to facilitate penetration of the yttrium chloride resulted in
`immediate slight haziness of the cornea, with subsequent increasing opacity in the
`next several days. Finally the corneas became completely opaque and vascularized.
`Exposure to 0.01 M solution after removal of the epithelium resulted in slight to
`mild permanent opacification.
`Treatment by irrigation with neutral 0.01 to 0.1 M sodium edetate (EDTA) solu-
`tions for fifteen minutes immediately after exposure to yttrium chloride solution
`prevented much of the opacification and vasculariiation. Similar treatment with
`sodium chloride solution was without appreciable effect.88 (Compare Rare-earth salts;
`see INDEX.)
`Zinc chloride and zinc sulfate are described together because they have strong
`similarities in their properties,
`though injuries of the cornea have been more
`commonly related to the chloride than to the sulfate, and most animal experiments
`have been carried out with the chloride. Both salts are white, odorless solids, very
`soluble in water (1 g in 0.5 or 0.6 ml of water, forming slightly acid solutions, pH 4 or
`4.5). Zinc chloride is used in high concentration in soldering fluxes, galvanizing
`baths, sometimes in golf balls, and in “chemosurgery” of skin cancer. Dilute solu-
`tions (0.2% to 1%) have long been used as astringent eyedrops without difficulty, but
`concentrated solutions and pastes such as encountered industrially have caused very
`severe injuries of the cornea in numerous cases of accidental splash in the eye.
`The following description is organized to present information on the toxic effects
`in the following order: (a) human eye injuries from concentrated zinc chloride,
`
`
`
`
`
`
`
`lll
`
`

`

`Encyclopedia of Chemicals, Drugs, Plants, Extras, and Venom:
`
`987
`
`(b) eye injuries from concentrated zinc sulfate. (c) animal experiments with zinc
`chloride, and (d) clinical experience with dilute zinc salt solutions.
`
`Human eye injuries from concentrated zinc chloride. These have been reported
`several times since 1903. Lewin and Guillery and Wagenmann summarized what
`had been reported to 1913.153'253 Tillot, according to Wagenmann, reported the first
`case of corneal ulceration and iritis, but eventual partial recovery, after accidental
`splash of a concentrated zinc salt in 1903.
`Zur Nedden reported in detail concerning a workman who splashed a zinc
`chloride solution of unstated concentration in one eye. causing at first only some
`redness, and persistent discomfort, but within six days leading to a discrete stromal
`opacity in‘ the lower part of the cornea with irregularity of the overlying epithelium.268
`The opacity was grayish, located in the anterior layers of the stroma. During the
`next month, while some portions cleared, the remainder became dense white, and
`was thought to be a zinc encrustation. A discrete white opacity covered by epithe-
`lium remained, and because it was in the lower part of the cornea did not affect
`vision. Strader also reported a case of partial irreversible corneal opacification from
`zinc chloride burn.“
`
`Van Lint described a workman who had splashed in one eye a liquid composed of
`zinc chloride, ammonium chloride, iron chloride, and hydrochloric acid, producing
`a hum of the cornea, and subsequently white spots in the front of the lens.° At six
`weeks after the injury the cornea still had stromal infiltration. The lens showed a
`great many white spots of varied shape beneath the anterior capsule, smaller than
`initially. From 2.5 to 6 months after injury the vision recovered only from 1/10 to
`1/5, with a correcting spectacle. The impairment of vision was due to abnormality of
`the cornea rather than to the anterior snbcapsular lens changes. The deeper parts of
`the lens remained normal.
`
`Rzehullta described in detail a patient who had an eye accidentally burned by
`instillation of one drop of 50% zinc chloride solution!" There was immediate severe
`pain, which persisted despite immediate irrigation with water. The corneal epithe-
`lium became eroded. Large folds developed in Descemet's membrane, and the
`corneal stroma was turbid. This was accompanied by severe iritis with small hemor-
`rhages in the iris. Deep and superficial vascularization of the cornea followed. The
`eye was treated with mydriatic and cortisone eyedrops and 5% neutral ammonium
`tartrate eye bath. In four months the cornea cleared sufficiently to permit 6/8 vision.
`De Rose described a workman who splashed a reaction mixture of zinc and
`hydrochloric acid in one eye, causing great pain.a After irrigation of the surface, the
`cornea was found to have lost its epithelium but the stroma appeared transparent.
`Two days later most of the cornea was transparent, but for the first time small
`opacities appeared in the anterior cortical layers of the lens. Vision was reduced to
`1/12 and the intraocular pressure was subnormal. At six days the anterior cortical
`lens opacity was more diffuse and the aqueous turbid. At ten days the surface of the
`cornea was almost healed, but the lens opacity and turbidity of the aqueous were
`more accentuated, and much pigment became deposited on the posterior surface of
`the cornea. The intraocular pressure remained low, and treatment with mydriatics
`and local corticosteroid was continued. At twenty days the patient had acute glau-
`
`

`

`
`
`988
`
`Toxicology of the Eye
`
`coma with pain, corneal edema, and tension of 50 mm Hg, responding to treatment
`with oral acetazolamide during several days, but at about thirty days from the injury
`the glaucoma and pain returned. The cornea was diffusely clouded by edema and
`much pigment on the posterior surface. A scleral staphyloma developed. Vision was
`so low and pain so great that the eye was enucleated. Histologic examination
`confirmed extensive dissemination of pigment on the back surface of the cornea and
`in the trabecular meshwork. Also, iridocorneal synechias were present irregularly.
`The iris was mostly degenerated, with nearly complete loss of pigment. The lens
`had become cataractous. It was believed that these extensive injuries were attribut—
`able to the action of zinc chloride. The glaucoma was believed to have been due to
`infiltration of the trabecular meshwork with pigment.
`Houle and Pavari—Langston have reported on two patients who had severe damage
`to their eyes from concentrated zinc chloride.“k One of these patients had zinc
`chloride solder-flux paste splashed into one eye. The other patient had his eyes
`accidentally drenched by concentrated zinc chloride solution used in galvanizing
`steel. Both patients within the next day or two developed changes in the appearance
`of their eyes that was remarkably similar to the appearance of eyes that have very
`recently undergone severe acute attacks of angle-closme glaucoma. These eyes had
`extensive corneal edema. with wrinkling of the posterior surface, cells in the aque-
`ous humor, and small discrete spots of gray opacity on the front of the lens, exactly
`like Glaukomflecken. Both patients took many months for subsidence of their
`corneal edema and for recovery of useful vision. Glaucoma was not a problem in
`these patients, but acetazolamide was given with the hope of making the intraocular
`pressure lower than normal. Corticosteroids given systemically seemed to help
`relieve discomfort and photophobia that developed after the corneal epithelium
`(and presumably the corneal nerves) regenerated. In these cases, as in those previously
`described in the literature, the spots in the lenses that were evident within the first
`few days after injury not only looked like Glaukomflecken. but also subsequently
`behaved like Glaukomflecken, persisting, but tending to becomesmaller, and caus-
`ing no significant trouble. The corneas were the great problem.
`In treatment of cancer of the eyelid and closely neighboring skin. Mohs has used
`a saturated solution of zinc chloride made into a paste by addition of powdered
`stibnite (antimony trisulfide) and sanguinaria powderfi'h Fortunately, injury to the
`eye has [not occurred. This may be explained by the factthat the paste has been
`applied to the outer surface of the eyelid, and care has been taken not to bring the
`paste into direct contact with the eye.
`
`Human eye infufies from concentrated zinc sulfate solutions. These seem all
`to have been reported in the 1950’s as a complication of use of 20% zinc sulfate
`solution for treatment of dendritic keratitis, recurrent erosion, and ulcus serpens.
`Prior to 1955 the application of 20% zinc sulfate solution on a swab directly to such
`ulcers was considered to be fairly safe, and though some cursory mention had been
`made of occasional delicate branching opacities which had developed under the
`anterior lens capsule. such c0mplications were considered to be rareJ-‘xi Pillat presented
`the first detailed description of cases of white flecks induced in the lens after
`cauterization of the cornea with 20% zinc sulfate, having the characteristic appear-
`
`
`
`
`
`
`
`

`

`Encyclopedia of Chemicals, Drugs, Plants, Toxins, and Venoms
`
`989
`
`ance of the “Glaukomflecken” of Vogt, such as typically are associated with acute
`attacks of glaucoma, but Pillat established that in these cases there were no eleva-
`tions of intraocular pressure}
`Filipovic reported that in three cases cauterization of herpetic dendritic keratitis
`with 20% zinc sulfate solution caused Glaukomflecken to appear by the next day.b
`The corneas became gray, but cleared while the flecks in the lenses remained. The
`same author noted that he had used 10% zinc sulfate solution in treating dendritic
`keratitis in three children, and that this had cured the keratitis and had caused no
`
`lens opacities. (All reports of Glaukomflecken had involved use of more concen-
`trated solution in adult patients.)
`
`Am'fizal experiments with zinc chloride solutions. Experiments probably were
`undertaken before 1885, according to Hoffman, who mentioned that application of
`zinc chloride to frogs‘ eyes had been reported to cause purulent keratitis,d but the
`first significant observations from experiments appear to have been made by Zur
`Nedden, who experimented on enucleated pig eyes.268 He found that 'he could
`produce a grayish. but not a white, opacity of the cornea by applying zinc salts, and
`this could be done easier with zinc chloride than zinc sulfate. His experiments led
`him to believe that the opacifications were due to formation of a zinc—mucoid
`precipitate, not due to a zinc-collagen combination, and he concluded that there was
`little or no formation of zinc carbonate.
`
`Cuillery found that when he applied 50% zinc chloride solution repeatedly to one
`eye of an albino rabbit, it caused opacity of the cornea, and that six days later the eye
`had become very hard. with extensive hemorrhage in the anterior segment, and that
`there was much infiltration with inflammatory cells, loss of corneal endothelium,
`and clouding of the anterior portion of the lens.96
`Johnstone and Sullivan investigated whether using sodium edetate (EDTA) in
`first aid treatment of eyes contaminated with zinc chloride might be beneficial.f
`They measured the turgescence properties of pieces of bovine cornea in water and
`obtained evidence that denaturation or fixation occurred when cornea was brought
`into contact with zinc chloride solution. When pieces of cornea were exposed to 50%
`zinc chloride solution and were subsequently placed in water they were found to
`have lost 85% of their normal capacity to swell, and only about 5 per cent of their
`normal swelling capacity could be restored by treatment with edetate. When cornea
`was exposed to only 1.36% (0.1M) zinc chloride solution, the swelling in water was
`similarly inhibited, but by treatment with edetate about half of the swelling capacity
`was restored.
`
`Johnstone and Sullivan exposed the eyes of rabbits to 50% zinc chloride solution in
`a standard manner for one minute. When the eyes were irrigated with 0.05 M
`sodium edetate, starting one minute after termination of exposure to zinc chloride,
`the corneas developed during the next four days a degree of opacification similar to
`that of the corneas irrigated with sodium chloride, but then they showed progressive
`improvement, and by two weeks had relatively slight residual opacity. The edetate—
`treated eyes b‘ecame strikingly better than those irrigated with sodium chloride.
`Unfortunately, if the interval from termination of exposure to beginning of irriga~
`tion with edetate solution was increased to five minutes, the treatment gave no
`
`

`

`e._-_-;.eeana--..,....w.
`
`AA‘
`
`990
`
`Toxicology of the Eye
`
`evident benefit, and at two weeks the corneas were densely opaque. It was concluded
`from these experiments that irrigation with neutral sodium edetate solution would
`be worthwhile in immediate or first aid treatment of patients who had splashed zinc
`chloride into their eyes, but that it would have to be started very quickly to be of
`benefit.
`
`Clinical experience with dilute zinc salt solutions. As already mentioned,
`solutions up to 1% concentration appear almost never to have caused injury, but
`Paul reported a single case in which a patient’s cornea developed an intense white
`precipitate in one small portion of an ulcerated area that had been treated repeatedly
`over a long time with 0.5% to 1% solution of zinc salt, probably zinc sulfate. He
`considered this to beat zinc encrustration rather than a burn)
`
`a. DeRosa C: On a case of severe ocular caustic action ofa zinc salt. RASS ITAL OTTALMOL
`
`28:280—290, 1959. (Italian)
`I]. Filipovic A: On prevention of Vogt's acute subepithelial disseminated cataract after zinc
`hum of the cornea. KLIN MONATSBL AUGENHEILKD 1331263-269, 1958. (German)
`1:. Fleischanderl A: On treatment of recurrent erosionJflJN MONATSBL AUGENHEILKD
`
`125:747-748, 1954. (German)
`d. Hoffman FW: On keratitis and the development of hypopyon. BER OPHTHALMOL
`GESELLSCH HEIDELBER017W67—80 1885. (German)
`e. Houle RE, Grant WM: Zinc chloride keratopathy and cataracts. AM ] OPHTHALMOL
`75:992—996, 1973.
`
`f. Johnstone MA, Sullivan WR, Grant WM: Experimental zinc chloride ocular injury
`and treatment with disodiurn edetate. AM I OPHTHALMOL 76:137—142, 1973.
`g. Mohs FE: Chemosurgiml treatment of cancer of the eyelid. ARCH OPHTHALMOL
`39:43—59, 1948.
`
`h. Mobs FE: Chemosurgery. NE W YORK I MED, Apr 1, 1968, pp. 871~876.
`i. Nemetz U: On the question of acute glaucomatous cataract. KLIN MONATSBL A UGEN
`HEILKD 115:417—421, 1949. (German)
`j. Paul L: 011 corneal ulcerations [tom diplobacilli. KLIN MONAII‘SBL AUGENHEILKD
`43:154484, 1905. (German)
`k. Pawn-Langston D: Personal communication, 1970.
`l. Pillat A: On the development of Vogt‘s acute anterior subepithelial disseminated
`cataract alter zinc hum of the cornea. KLIN MONATSBI. AUGENHEILKD 126:561—568,
`1955. (German)
`m. Rzehullm G: On bums of the eye with zinc chloride. KLIN MONATIS'BL A UGENHEILKD
`130:53SL544, 1957. (German)
`
`n. Stradei-z COLORADO OPHTHALMOL SOC 21, 1908. (Reference from Guillery, 1910.96)
`0. Van Lint M: Vogt’s subepithelial disseminated cataract of traumatic origin. BULL SOC
`BELGE OPHTALMOL 72:62—65, 1936. (French)
`
`Zinc phenosulfonate (zinc sulfocarbolate) has been used as an astringent, and
`insecticide.171 A single instance has been reported in which use of a 3% solution in
`eye compresses resulted in complete necrosis of both corneas of an infant.3 Experi-
`mental application of this solution eight times to the eye of a rabbit caused the
`cornea to become completely opaque in seven days.
`
`.lAh'mw
`
`u.;.,4:~.~.-e,;,c..
`
`
`4...”;1...}"'2...40‘
`1
`
`.l
`
`l;
`E!.3
`
`
`
`
`
`

`

`Encyclopedia of Chemicals, Drugs, Plants, 72mins, and Venoms
`
`991
`
`a. Velhagen K: A disastrous iatrogenic eye injury. KLIN MONATSBL AUGENHEILKD
`1261580—585, 1955.
`
`‘Zinc pyrithione (zinc pyridinethione; zinc omadine; zinc-2-pyridinethion—l—oxide‘;
`the zinc chelate of pyrithione) is an antifungal, antibacterial compound that has
`been used as an antidandruff agent in shampoo formulations, such as Head and
`Shoulders Shampoo. When tested on rabbit and monkey eyes by application of 0.5%
`to 2% suspensions as used in shampoos. it was found not to be injurious,"-c although
`1% in dimethyl sulfoxide caused irritation comparable to 70% isopropyl alcohol}-62
`Systemic administration of zinc pyrithione, and also pyrithione itself, has demon-
`strated interesting species differences in toxic effects. When zinc pyrithione has been
`administered systemically to dogs, it has produced blindness, associated with detach-
`ment of the retina. This same effect was produced by pyritlu'one without zinc.
`However, no such effects on the retina were produced in rats, rabbits, or monkeysfi-fid
`In cats, orally administered zinc pyrithione has caused tapetal degeneration and
`atrophy, but not the Severe reaction seen in dogs, which have shown not only
`degeneration of tapetal cells but also tapetal and retinal inflammation with intraretinal
`hemorrhage, and subretinal edema leading to retinal detachment and blindness.a
`It has been of partiCular interest that normal beagle dogs which have a tapetum
`lucidum show this reaction, While another variety of beagle dog which lacks a
`tapetum lucidum does not show injury. This corresponds to lack of reaction in
`monkeys, human beings, rats and rabbits which also do not have this structure.
`It is of interest, as pointed out by Cloyd et al, that the tapetum lucidum is
`rich in zinc, and that certain metal chelating agents (dithizone and diethyldithio—
`carbamate) injure the normal dog's eye in the same manner as pyrithione and
`zinc pyrithione.a However, they also point out that ethambutol and related com—
`pounds that can chelate the zinc of the tapetum lucidum only cause a loss of
`color of the tapetum which is reversible. and do not cause inflammatory and
`degenerative changes. Cloyd et al have suggested that zinc pyrithione (as well
`pyrithione. dithizone, and diethyldithiocarbamate) may not only chelate some of
`the zinc of the tapetum but may also react with sulfhydryl groups that are necessary
`for important metabolic processes in that region. (See INDEX for Pyrithione, DiZhizone,
`and D'ethyldt'thiocarbamate.)
`
`a. Cloyd GG, Wyman M, et al: Ocular toxicity studies with zinc pyridinethione. TDXICOL
`APP]. PHARMACOL 45:771—782, 1978.
`h. Opdylte DL, Burnett CM, Brauer FAN: Antiseborrheic qualities of zinc pyrithione in a
`cream vehicle. II. Safety evaluation. FOOD COSMET TOXICOL 5:321—326, 1967.
`c. Snyder FH. Buehler EV, Winak CL: Safety evaluation of zinc 2—pyridinethiol—1—oxide
`in a shampoo formulation. TOXICOL APPL PHARMACOL 7:425—437. 1965.
`d. Winek CL, Buehler EV: Intravenous toxicity of zinc pyridinethione and several zinc
`salts. TOXICOL APPL PHARMACOL 9:269-273, 1966.
`
`Zinc sulfide, a pigment, has been identified in the tissues of the conjunctivae and
`lids of two children who were accidentally squirted with material from the liquid
`center of golf balls. The zinc sulfide, as well as barium sulfate which was similarly
`encountered, produced only slight mauophage reaction and negligible tissue damage.8
`
`

`

`
`
`992
`
`Toxicology of the Eye
`
`21'. Johnson FB, Zimmerman LE: Barium sulfate and zinc sulfide deposits resulting from
`golf-ball injury to the conjunctiva and eyelid. AM J CLIN PATH 411-533—538, 1965.
`
`Zinc systemic levels, particularly the concentrations measured in the plasma or
`serum, are found to be subnormal in certain diseases and some toxic conditions.
`
`Reviews of the biochemistry and physiology of zinc make clear that zinc has many -
`important natural functions in the eye, but adverse effects on the eyes that may
`result from deficiencies of zinc are much less well deiinediP
`
`The following are some of the clinical correlations that have been made in which
`no toxic substances were involved and ocular effects were believed to be secondary to
`reduction of systemic zinc levels by systemic diseases. In chronic liver disease, such
`as alcoholic cirrhosis, dark adaptation has been impaired,3-iv"‘ and in some patients
`dark adaptation improved when zinc was administered; in these patients treatment
`with vitamin A had failed!" Similarly in a patient who had abnormal dark adapta-
`tion associated with Crohn’s disease and low serum zinc, there was improvement of
`the dark adaptation when zinc was administered.l Another patient with Crohn’s
`disease, and very low serum zinc following parenteral administration of nutrition,
`had paracentral scotomas which disappeared when the zinc deficiency was corrected.h
`In rats, severe diet—induced zinc deficiency has caused accumulation of osmiophilic
`inclusion bodies in the retinal pigment epithelium and degeneration of outer
`segments of photoreceptors.It Patients with dietary zinc deficiency, or failure to
`absorb zinc, as in acrodermatitis enteropathica, may have serious general effects
`without visual symptoms.
`When exposure to toxic substances is associated with low zinc levels, it is difficult
`to assess the role of the deficiency of zinc in adverse effects on the eyes. The
`following are circumstances involving tOxic substances and adverse effects on the
`optic nerves with decrease of vision. sometimes optic atrophy, associated with
`subnormal plasma or serum zinc.
`In 1975 Samux and colleaguesn followed up earlier reports of effects of ethambutol
`on zinc in experimental animals (see INDEX for Ethambulol), and reported that a
`single serum zinc measurement in each of 3 patients with retrobulbar neuritis and
`central scotoma from ethambutol (plus ioniazid in 2 of the patients) shawed subnor—
`mal zinc levels averaging 0.75 mg/l compared to normal controls of 1.09 mg/l. Also
`they reported that one patient with optic neuropathy from disulfiram (see INDEX
`for Dz'sulfimm] had 0.95 mg/l. Furthermore, they found that out of 7 patients with
`alcohol-tobacco retrobulbar neuritis, 3 had zinc levels as low as 0.75, while the other
`
`4 were in the range of 0.90 to 1.00.‘‘1 However, subsequent measurements before and
`after varying periods of treatment with ethambutol {for tuberculosis) did not Show a
`reduction of zinc levelsfivdve [t was then suggested that when pre-treatment zinc
`levels were low this increased the risks of retrobulbar neuritis.d-'a This Was supported
`by an observation that of 108 patients with pre-treatment plasma zinc above 0.8 mg/l
`none had any visual disturbance, but that 7 out of 20 with zinc below 0.8 mg/l had
`decreased visual acuity with central scotoma; 3 of these appeared to have macular
`degeneration.e
`'
`_
`The relationshipof alcohol-tobacco amblyopia and systemic zinc. after the report by
`Saraux,“ were studied further by Gerhard in 1982,‘ finding in half the cases serum
`
`
`
`

`

`Encyclopedia of Chemicals, Drugs, Plants, Toxins, and Venoms
`
`993
`
`"zinc ranged from 0.45 to 0.85 mg/l, compared to normal values of 1.0 to 1.2 mg/l.
`These patients had evidence of alcoholic cirrhosis which might acc0unt for the
`abnormal zinc levels. In another 52 cases of alcohol-tobacco optic neuropathy,
`Bechetoille and colleagues found significant subnormality of systemic zinc levels,
`slight subnormality of magnesium, normal copper, and lead above normal.a Eight
`patients with central scotomas attributed to alcohol and tobacco were given 400 mg
`of zinc sulfate per day, and nine others were given a placebo. (No vitamins were
`given, but alcohol intake and smoking were reduced during the trial.) After a month
`the visual acuity and color vision were improved in both groups. but not significantly
`more in the treated than in the control group. Only by special examination of the
`central 5°‘of visual field with the Friedmann analyzer was there evidence of some
`superiority in those with the zinc treatment.13
`In another group of 10 patients with alcohol-tobacco retrobulbar neuritis, Grignolo
`found serum zinc significantly lower than in 10 controls. Then, after 60 days of
`medical treatment (not described), 6 of 10 had improvements in visual acuity, visual
`field or chromatic sense, and these patients showed increase in their zinc levelsfi
`Iodoquinol (diiodohydroxyquin) formerly was used in treatment of acrodermatitis
`enteropathica, an inherited disease with failure of zinc absorption. which now is
`more effectively treated by administering zinc. (See INDEX for Iodoquz'nol.) The old
`treatment with iodoquinol may have aided absorption of zinc, but in a small number
`of cases the treatment led to optic atrophy. Acrodermatitis enteropathica is gener—
`ally lethal when untreated, but, since it is not known to cause optic neuropathy,
`some have considered that the optic atrophy associated with iodoquinol treatment to
`be a toxic effect of the drug. Others have proposed that the optic neuropathy might
`be attributable to severe zinc deficiency, and that the iodoquinol merely helped the
`patients to survive long enough to manifest the optic neuropathy from the deficiencyP’P
`If any conclusion is warranted, it seems to be that the relationship of zinc defi—
`ciency to optic neuropathy is in need of further study.
`a. Bechetoille A, Allain P, et al: Modifications of blood concentrations of zinc and lead
`
`and the activity of ALAdehydratase in the course of alcohol-tobacco optic neuropathies.
`I FR OPHTALMOL 63:231-435. 1983. (French)
`b. Bechetoille A, Ebran JM, et a1: Therapeutic effect of Zinc sulfate on the central scotoma
`of alcohol-tobacco optic neuropathies. ] FR OPHTALMOL 6:237-242, 1983. (French)
`c. Campbell IA, et al: Ethamhutol and the eye; zinc and copper. LANCET2z'711, 1975.
`cl. Deloux E, Moreau Y, et al: Prevention of ocular toxicity of ethambutol. 1 FR
`OPHTALMOL 1:191—196, 1978. (French)
`e. Fioretli F, Minervino M: Zincemia as a clue to the ocular toxicity of ethambutol. ANN
`OTTALMOL CLIN OCUL 106:543~548, 1980. (Italian)
`f. Gerhard JP: On an advanceconcerning ocular zinc. BULL SOC OPHTALMOL FRANCE
`82:1125—1127, 1982. (French)
`g. Grignolo FM, La Rosa G, et al: Evaluation of plasma zinc in retrobulbar optic
`neuropathies. BOLL OCULIST 59:801—821. 1980. (Italian)
`h. Haas]: Acute zinc deficiency syndrome. AKTUEL NE UROL 9:55—57, 1982. (German)
`
`i. Karcioglu ZA: Zinc in the eye. SURVEY OPHTHALMOL 27:114—122, 1982.
`j. Keeling PWN, O‘Day J, et al: Zinc deficiency and photoreceptor function in chronic
`liver disease. CLIN SCI 62:109-111, 1982.
`
`

`

`Tbxicologj! of the Eye
`
`. Leure—duPree AE, Mc Clain C]: The effect of severe zinc deficiency on the morphology
`of the rat pigment epithelium. [N VEST OPHTHALMOL VIS SCI 23:425—434, 1982.
`. Mc Clain C], Su LC, et al: Zinc-deficiency—induced retinal dysfunction in Crohn’s
`disease. DIG DIS SCI 28:85—87, 1983.
`
`. Morrison SA, Russell RM, et a1: Zinc deficiency: A cause of abnormal dark adaptation
`in cirrhotics. AM ] CLIN NUTR 31:276—281, 1978.
`, Samux H. Bechetoille A, et al: The diminution of the level of serum zinc during some
`toxic optic neuritis cases. ANN OCULIST 208:29—31, 1975. (French)
`. Sturtevant FM: Zinc deficiency, aa‘odermatitis enteropathica, optic atrophy, subacute
`myelo—opticmeuropathy, and 5,7-dihalo-8-quinolinols. PEDIATRICS 65:61M13, 1980.
`. Wong EK Ir, Leopold 1H: Zinc deficiency and visual dysfunction. METAB PEDIAH
`OPHTHALMOL 321—4, 1979.
`
`Zyldon A, a fumigant mixture of 90% methyl cyanocarbonate and 10% methyl
`chlorocarbonate, was inhaled and caused acute poisoning in a man who survived
`collapse and convulsions, but then had reduced visual acuity with macula edema. In
`subsequent weeks the visual acuity returned essentially to normal, but many pig-
`ment flecks developed in the fundi, particularly in the neighborhood of the foveas.
`The patient died with nephrosis 2 months after poisoning.
`
`a.
`
`Illig KM: Retinal injury by cyanide poisoning. KLIN MONATSBL AUGENHEILKD
`120:310—312, 1952. (German)
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket